Goodwin advised Bregal Sagemount, a leading growth-focused private equity firm, on its investment, alongside Ardian, in Ennov, a global provider of end-to-end regulatory, quality, and clinical software solutions for life sciences and healthcare companies.
The investment will support the company’s continued expansion, with a focus on AI innovation, global go-to-market acceleration, and scaling its product offering.
Founded and headquartered in Paris, Ennov provides a unified compliance platform for global life sciences organizations. The platform supports key domains including Regulatory, Quality, Commercial, Clinical, and Pharmacovigilance. Its integrated architecture and unified data model enable faster deployment, improved user adoption, consistent compliance, and AI-driven efficiency across global operations.
The Goodwin team included:
- In France, Simon Servan-Schreiber, Louis Jambu-Merlin, Ornella Youkharibache, and Daphnée Rübcke on corporate matters, Adrien Paturaud, Benjamin Filiatre, and Elisa Revel on financing matters, Marie-Laure Bruneel and Thibault Dulac on tax matters, and Marie Fillon and Albana Taipi on IP matters.
- In the US, Jared Spitalnick, Andrew Sunol, and Lana Gandler on corporate matters, George Davis on tax matters, and Jennifer Bralower and Maciej Zielnik on financing matters.